UBS Investment Bank has announced coupon payments for five ETRACS Exchange Traded Notes (ETNs) listed on the NYSE Arca and expected payments for three ETNs traded on NASDAQ. These announcements pertain to notes linked to various indices, including the Solactive US High Dividend Low Volatility Index Series B, Solactive US Small Cap High Dividend Index Series B, Solactive Preferred Stock ETF Index, S-Network Composite Closed-End Fund Index, Market Vectors Global Mortgage REITs Index, Credit Suisse Nasdaq Gold FLOWSTM 103 Index, Credit Suisse Nasdaq Silver FLOWSTM 106 Index, and Credit Suisse Nasdaq WTI Crude Oil FLOWSTM 106 Index.
The company cautions that these forward-looking statements are subject to risks and uncertainties. Actual results may differ materially from those anticipated. UBS states that these expectations are based on current assumptions but could change due to unforeseen circumstances.
"Forward-looking statements," as defined by UBS AG in their announcement, "are based on management’s current expectations and assumptions." The firm emphasizes the importance of understanding the risks associated with investing in these securities by referring investors to the "Risk Factors" section in relevant prospectus supplements.
ETRACS ETNs are unsecured notes issued by UBS AG and can be bought or sold through brokers or financial advisors. They carry risks including potential loss of principal and depend on UBS AG's creditworthiness. Investors are not guaranteed any coupon or distribution amount under these ETNs.
For more information about investing in ETRACS ETNs, UBS recommends reading the relevant prospectus available through EDGAR on the SEC website or by contacting them directly at a provided toll-free number.
UBS is a global wealth manager headquartered in Zurich with operations in over 50 markets worldwide. It offers diversified asset management solutions and investment banking services. The firm's shares are listed on both the SIX Swiss Exchange and New York Stock Exchange.
The announcement includes disclaimers regarding potential inaccuracies from data sources like Solactive AG and S-Network Global Indexes Inc., emphasizing no liability for errors or omissions related to index data.
Media inquiries can be directed to Alison Keunen at +1-212-713-2296 or via email at alison.keunen@ubs.com. Institutional investors can contact +1-877-387 2275 for further details.